![](https://tracker.live.rns-distribution.com/track.live-rns/5012637_75d1671758db0ed18eba2dbba83793b2.png)
James Cropper plc
(the "Company")
Director/PDMR Shareholding
The Company has been notified that on 21 December 2023, Patrick Willink (Chief Innovation Officer) purchased 3,626 Ordinary Shares of 25p each ("Shares") in the Company. The Shares were purchased from a family trust of which Patrick Willink is a trustee.
As a result of the transaction, Patrick Willink's beneficial interest in the Company has increased by 3,626 Shares, and his non-beneficial interest has decreased by 3,626 shares. Patrick Willink's interests in the Company are currently as follows:
| Number of shares | % of issued share capital |
Beneficial shareholding | 61,705 | 0.65% |
Non-beneficial shareholding | 108,058 | 1.13% |
Patrick Willink and members of the Cropper, Willink and Acland families are deemed to act in concert and are regarded by the Takeover Panel as being members of a concert party as detailed in the Company's circular to shareholders dated 30 June 2015 (the "Concert Party"). The Concert Party has a collective interest in 3,598,609 Ordinary Shares representing 37.7% of the Company's issued share capital.
Enquiries
James Cropper plc
Matt Ratcliffe, General Counsel and Company Secretary
Tel: +44 (0) 1539 722 002
Shore Capital - (NOMAD and Broker)
Robert Finlay, Henry Willcocks, Lucy Bowden
Tel: +44 (0) 7601 6100
Buchanan Communications - Financial PR
Chris Lane, Charles Ryland, Jamie Hooper, Verity Parker
jamescropper@buchanancomms.co.uk
Tel: +44 (0) 207 466 5000
The following information is included in accordance with Article 19(3) of the Market Abuse Regulation (No. 596/2014):
1. | Details of person discharging managerial responsibilities/person closely associated
| |||||||
a) | Name | Patrick Willink | ||||||
2.
| Reason for the notification | |||||||
a) | Position/status | Chief Innovation Officer
| ||||||
b) | Initial notification/amendment | Initial Notification | ||||||
3. | Details of the issuer
| |||||||
a) | Name | James Cropper plc
| ||||||
b) | Legal Entity Identifier | 213800XM78VTDYGBRM93
| ||||||
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted.
| |||||||
a) | Description of the financial instrument | Ordinary Shares of 25 pence each | ||||||
b) | Identification code of the Financial Instrument | GB0002346053 | ||||||
c) | Nature of the transaction | Purchase of Ordinary Shares | ||||||
d) | Currency | GBP
| ||||||
e) | Price(s) and volume(s) |
| ||||||
f) | Aggregated information - volume - Price - Total
|
3,626 £6.30 £22,843.80 | ||||||
g) | Date of the transaction | 21 December 2023 | ||||||
h) | Place of the transaction | Outside trading venue
|
1. | Details of person discharging managerial responsibilities/person closely associated
| |||||||
a) | Name | Patrick Willink (as trustee of a family trust) | ||||||
2.
| Reason for the notification | |||||||
a) | Position/status | Chief Innovation Officer
| ||||||
b) | Initial notification/amendment | Initial Notification | ||||||
3. | Details of the issuer
| |||||||
a) | Name | James Cropper plc
| ||||||
b) | Legal Entity Identifier | 213800XM78VTDYGBRM93
| ||||||
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted.
| |||||||
a) | Description of the financial instrument | Ordinary Shares of 25 pence each | ||||||
b) | Identification code of the Financial Instrument | GB0002346053 | ||||||
c) | Nature of the transaction | Sale of Ordinary Shares | ||||||
d) | Currency | GBP
| ||||||
e) | Price(s) and volume(s) |
| ||||||
f) | Aggregated information - volume - Price - Total
|
3,626 £6.30 £22,843.80 | ||||||
g) | Date of the transaction | 21 December 2023 | ||||||
h) | Place of the transaction | Outside trading venue
|
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.